David Michod

657 total citations
18 papers, 488 citations indexed

About

David Michod is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, David Michod has authored 18 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology. Recurrent topics in David Michod's work include Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (4 papers) and Cancer-related Molecular Pathways (4 papers). David Michod is often cited by papers focused on Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (4 papers) and Cancer-related Molecular Pathways (4 papers). David Michod collaborates with scholars based in Switzerland, United Kingdom and Germany. David Michod's co-authors include Christian Widmann, Jiang-Yan Yang, Joël Walicki, Paolo Salomoni, Maria Victoria Niklison-Chirou, Shailaja Kasibhatla, Séamus J. Martin, Brona M. Murphy, Pierluigi Nicotera and Laura Berliocchi and has published in prestigious journals such as Neuron, Genes & Development and Molecular and Cellular Biology.

In The Last Decade

David Michod

18 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Michod Switzerland 14 393 104 75 63 43 18 488
Amrik Singh United States 10 382 1.0× 88 0.8× 65 0.9× 54 0.9× 56 1.3× 13 498
BaoHan T. Vo United States 12 335 0.9× 114 1.1× 107 1.4× 38 0.6× 42 1.0× 15 502
Rahul Thorat India 15 337 0.9× 109 1.0× 90 1.2× 82 1.3× 38 0.9× 40 488
Óscar Meca‐Cortés Spain 9 315 0.8× 99 1.0× 110 1.5× 36 0.6× 41 1.0× 12 416
Xinnong Jiang United States 14 338 0.9× 111 1.1× 84 1.1× 124 2.0× 50 1.2× 20 564
Philippe Depeille United States 13 437 1.1× 162 1.6× 73 1.0× 53 0.8× 108 2.5× 15 616
С. С. Шушанов Russia 10 256 0.7× 99 1.0× 103 1.4× 54 0.9× 25 0.6× 26 393
Mark Badeaux United States 11 376 1.0× 236 2.3× 121 1.6× 44 0.7× 56 1.3× 15 608
Jason A. Lehman United States 13 317 0.8× 135 1.3× 45 0.6× 52 0.8× 63 1.5× 18 427
Kim Moran‐Jones Australia 13 465 1.2× 63 0.6× 92 1.2× 62 1.0× 36 0.8× 16 562

Countries citing papers authored by David Michod

Since Specialization
Citations

This map shows the geographic impact of David Michod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Michod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Michod more than expected).

Fields of papers citing papers by David Michod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Michod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Michod. The network helps show where David Michod may publish in the future.

Co-authorship network of co-authors of David Michod

This figure shows the co-authorship network connecting the top 25 collaborators of David Michod. A scholar is included among the top collaborators of David Michod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Michod. David Michod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Michod, David, et al.. (2023). SIMVASTATIN INHIBITS MEDULLOBLASTOMA CELL MIGRATION VIA TARGETING THE MEVALONATE PATHWAY. Neuro-Oncology. 25(Supplement_3). iii14–iii14. 1 indexed citations
2.
Meier, Stefanie L., Sandra Cantilena, Maria Victoria Niklison-Chirou, et al.. (2021). Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation. Cell Death and Disease. 12(8). 785–785. 13 indexed citations
3.
Michod, David, et al.. (2021). Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?. Cell Death Discovery. 7(1). 87–87. 13 indexed citations
4.
Varma, Swastina Nath, et al.. (2019). NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma. Cell Death and Disease. 10(11). 785–785. 19 indexed citations
5.
Michod, David, et al.. (2019). NPI-0052 and gamma-radiation induce a synergistic apoptotic effect in the most aggressive medulloblastoma subgroup. Neuro-Oncology. 21(Supplement_4). iv16–iv16. 1 indexed citations
6.
Niklison-Chirou, Maria Victoria, Mikael K.R. Engskog, Jakob Haglöf, et al.. (2017). TAp73 is a marker of glutamine addiction in medulloblastoma. Genes & Development. 31(17). 1738–1753. 50 indexed citations
7.
Salomoni, Paolo, Maria Dvorkina, & David Michod. (2012). Role of the promyelocytic leukaemia protein in cell death regulation. Cell Death and Disease. 3(1). e247–e247. 28 indexed citations
8.
Michod, David, Stefano Bartesaghi, Cristian Bellodi, et al.. (2012). Calcium-Dependent Dephosphorylation of the Histone Chaperone DAXX Regulates H3.3 Loading and Transcription upon Neuronal Activation. Neuron. 74(1). 122–135. 71 indexed citations
9.
Annibaldi, Alessandro, et al.. (2009). Role of the sub-cellular localization of RasGAP fragment N2 for its ability to sensitize cancer cells to genotoxin-induced apoptosis. Experimental Cell Research. 315(12). 2081–2091. 6 indexed citations
10.
Michod, David, et al.. (2009). Effect of RasGAP N2 Fragment–Derived Peptide on Tumor Growth in Mice. JNCI Journal of the National Cancer Institute. 101(11). 828–832. 24 indexed citations
11.
Salomoni, Paolo & David Michod. (2009). End of the Daxx diatribe?. Cell Cycle. 8(10). 1466–1470. 1 indexed citations
12.
Pittet, Olivier, David Petermann, David Michod, et al.. (2007). Effect of the TAT-RasGAP317–326 peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. Journal of Photochemistry and Photobiology B Biology. 88(1). 29–35. 19 indexed citations
13.
Michod, David & Christian Widmann. (2007). DNA-damage sensitizers: Potential new therapeutical tools to improve chemotherapy. Critical Reviews in Oncology/Hematology. 63(2). 160–171. 22 indexed citations
14.
Michod, David & Christian Widmann. (2007). TAT-RasGAP317-326 Requires p53 and PUMA to Sensitize Tumor Cells to Genotoxins. Molecular Cancer Research. 5(5). 497–507. 25 indexed citations
15.
Yang, Jiang-Yan, et al.. (2005). Impaired Akt Activity Down-Modulation, Caspase-3 Activation, and Apoptosis in Cells Expressing a Caspase-resistant Mutant of RasGAP at Position 157. Molecular Biology of the Cell. 16(8). 3511–3520. 34 indexed citations
16.
Michod, David, Jiang-Yan Yang, Jianhua Chen, Christophe Bonny, & Christian Widmann. (2004). A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells. Oncogene. 23(55). 8971–8978. 43 indexed citations
17.
Yang, Jiang-Yan, David Michod, Joël Walicki, & Christian Widmann. (2004). Surviving the kiss of death. Biochemical Pharmacology. 68(6). 1027–1031. 42 indexed citations
18.
Yang, Jiang-Yan, David Michod, Joël Walicki, et al.. (2004). Partial Cleavage of RasGAP by Caspases Is Required for Cell Survival in Mild Stress Conditions. Molecular and Cellular Biology. 24(23). 10425–10436. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amrik Singh Breakdown of academic impact, for papers by BaoHan T. Vo Breakdown of academic impact, for papers by Rahul Thorat Breakdown of academic impact, for papers by Óscar Meca‐Cortés Breakdown of academic impact, for papers by Xinnong Jiang Breakdown of academic impact, for papers by Philippe Depeille Breakdown of academic impact, for papers by С. С. Шушанов Breakdown of academic impact, for papers by Mark Badeaux Breakdown of academic impact, for papers by Jason A. Lehman Breakdown of academic impact, for papers by Kim Moran‐Jones
Rankless by CCL
2026